A study on the effect of ayurvedic detox therapies and herbal medicines in the management of chronic kidney disease

A Clinical Study To Evaluate The Effect Of Virechana Karma And Punarnavadi Niruha Basti Along With Shamana Chikitsa In Chronic Kidney Disease - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103080

Enrollment

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having serum creatinine level between 1.4 to 3.0 mg/dl for more than 3 months eGFR less than 60ml/min/1.73m2 for more than 3 months Patients indicated for Virechana karma and Basti karma.

Exclusion criteria

Exclusion criteria: Patient having serum creatinine level more than 3.0 mg/dl Female patients having pregnancy, breast feeding, post delivery period. Patients who are on renal replacement therapy, previous history of renal transplantation. Patients of hepato-renal insufficiency or renal insufficiency due to haemodynemic circulatory disorders and CCF, comobidities like cardio-vascular diseased, psychological diorders, serious acute organic diseases, liver disorders or metabolic disorders, any bleeding disorders. Patients contraindicated for Virechana karma and Basti karma.

Design outcomes

Primary

Measure	Time frame
changes in sign and symptoms & laboratory findings in chronic kidney disease by recording them before and after the administration of treatmentTimepoint: 30-45 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Mansi M Patel

J.S. Ayurveda Mahavidyalaya and P.D. Patel Ayurvedic Hospital

maitreemodh@gmail.com09408101041

Outcome results